Congratulations to Prof Julie Redfern on her appointment to the World Heart Federation (WHF) Science Committee.
The Science Committee is the cardiovascular health and policy evidence based advisory committee for the WHF. They provide strategic input, monitor new developments in cardiovascular science, assist with commissioning, reviewing and recommending appropriate medical and scientific statements and guidelines, position and policy papers, and science agenda of the WHF.
The RACP consultation on the new draft Cardiology Advanced Training curriculum has now closed. View the proposed changes on the links below…
Watch this short video for more about the curriculum development process and how to contribute to the consultation of the new specialty curricula. Or read more about the Advanced Training Curricula Renewal Project here.
Watch this short video for more about the curriculum development process and how to contribute to the consultation of the new specialty curricula. Or read more about the Advanced Training Curricula Renewal Project here.
For queries please contact RACP Member Services or [email protected] via email.
In this edition:
In this edition
Download this Cardiology_Practice_Review_Issue_24 here (pdf)
Applications are now open for the following 2024 UK structural and interventional fellowships:
ANZET-UK Structural Fellowship at Leeds General Infirmary
ANZET-UK Intervention Fellowship at Leeds General Infirmary
CSANZ-UK Interventional Fellowship at Wythenshawe University Hospital, South Manchester.
Details and eligibility criteria for the ANZET UK Fellowships can be found at this link.
Details and eligibility criteria for the CSANZ UK Fellowships can be found at this link.
To apply, please send a copy of your CV and letters of support from two supervisory consultants to A/Prof Ajay Sinhal at [email protected]
Applications close on Friday, 24 February 2023.
In this issue:
Transcatheter aortic valve implantation in patients with severe symptomatic aortic stenosis and low surgical risk. This review focuses on approved TAVI devices in Australia, advantages of TAVI vs SAVR, ACC/AHA guidelines and a series of relevant clinical studies.
Click on the link below to view the Research Review Webinar series online Cardiology Watch:
#3 SLG 2s in Heart Failure, presented by A/Prof John Amerena
# 2. Lipid Management to Prevent ASCVD; Targeting New Lipid Components, presented by Prof Philip Aylward.
Dr Christopher Yu at ESC 2022
Dr Christopher Yu, Nepean Clinical School, University of Sydney.
I was fortunate to be awarded the 2022 CSANZ ESC Travel Fellowship. This year, the conference was held in Barcelona, Spain and was the first face to face conference in three years due to the COVID-19 pandemic. It was surreal to find my long-lost passport and get back onto a long-haul flight.
I was excited to present part of my PhD at the conference, with two abstracts accepted as moderated poster presentations. The first abstract was a subgroup analysis of the SUCCOUR study assessing the role of baseline left atrial strain in predicting cardiotoxicity. The second abstract was assessing the role of cardiac magnetic resonance relaxometry in detecting anthracycline related changes compared to left ventricular ejection fraction. The presentations were well received, and it was great to receive feedback from the doyens of cardio-oncology. My PhD is under the supervisor of Professor Kazuaki Negishi, Nepean Clinical School, University of Sydney, to whom I am grateful for his supervision and mentorship.
The conference felt particularly special as the first ever cardio-oncology guidelines were launched by Dr Teresa Lopez-Fernandez and Dr Alex Lyon. The main hall was overflowing with attendees, and it was a highlight to feel the buzz and excitement at the largest cardiology conference in the world. It also demonstrated to me that there is so much work to be done in the field to improve the cardiovascular outcomes of our cancer patients. Other highlights included meeting fellow antipodeans and overindulging Catalan food and wine together.
I am extremely grateful to the CSANZ for supporting me to attend this fantastic conference. It has given me inspiration to expand my network and continue my research in cardio-oncology.
Ms Ada Lo at ESC 2022
Ada Lo is the lead sonographer at the Royal Brisbane and Women’s Hospital Cardiology Echo Lab.
I submitted two abstracts of my PhD projects to ESC 2022 and they were accepted as moderated posters.
My job at the Royal Brisbane and Women’s Hospital Cardiology Echo Lab involves training student sonographers and cardiology advanced trainees. I am also heavily involved in research projects and education.
I submitted two abstracts of my PhD project to ESC 2022, and they were accepted as moderated posters: the first moderated poster presented was “Use of advanced echocardiographic modalities to discriminate preclinical HCM mutation carriers from non-carriers”. The second, was entitled “Use of advanced echocardiographic deformation measures to delineate cause of pathological left ventricular hypertrophy: value of a multiparametric approach”.
This was my first time to attend the world class conference, ESC 2022 Congress, and the experience was fantastic. However, I did find that many talks that I attended at the ESC had already been presented in our own CSANZ Annual Scientific Meeting just two weeks prior. I really want to congratulate the organizing committee of our own CSANZ who give us a world class annual meeting.
I was also invited to present in the CSANZ Highlights session on the second day of this conference. It was a great privilege to present together with several experts in Cardiology from Australia. I really enjoyed the interesting case presentations and other moderated abstracts presented from centres around the world. It gave me new insights of how some new measurements can be of use in either research or clinical aspects.
Finally, I want to thank the CSANZ committee for the sponsorship of my trip.
